Skip to main content
. 2022 Sep 3;25(10):105054. doi: 10.1016/j.isci.2022.105054

Table 2.

Pricing comparison of FGF2 and TGF-β1 produced “in-house” versus commercially sourced (R&D Systems commercial source as reference)

Growth Factor Final conc. (mg/L) in media “In house”
Cost/L (CAD)
R&D Systems
Cost/L (CAD)
Pricing Comparison (fold-change)
FGF2 (100 ng/mL) 0.1 $1.02 $260.00 255× reduction
TGF-β1 (10 ng/mL) 0.01 $0.10 $72.00 720× reduction

GF concentrations calculated based on TGF-β1 and FGF2 usage levels in Essential 8 media.